SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-242002
Filing Date
2022-09-09
Accepted
2022-09-09 16:30:54
Documents
13
Period of Report
2022-09-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d397453d8k.htm   iXBRL 8-K 25711
2 EX-10.1 d397453dex101.htm EX-10.1 9892
  Complete submission text file 0001193125-22-242002.txt   163266

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cprx-20220908.xsd EX-101.SCH 2878
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20220908_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20220908_pre.xml EX-101.PRE 11725
7 EXTRACTED XBRL INSTANCE DOCUMENT d397453d8k_htm.xml XML 3443
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 221236526
SIC: 2834 Pharmaceutical Preparations